Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ryan

Showing results (581-590 of 649) with videos related to

Pageof 65
Sort By:
Oral Oncology|October 1, 2023
Loss of LRP1B expression drives acquired chemo and radio-resistance in HPV-positive head and neck cancerMushfiq H Shaikh, Alice Dawson, Stephenie D Prokopec, et al.
BJS Open|May 8, 2021
Prediction of 90-day mortality after surgery for colorectal cancer using standardized nationwide quality-assurance dataR P Vogelsang, R D Bojesen, E R Hoelmich, et al.
BMJ (Clinical Research Ed.)|June 21, 2022
Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort studyXintong Li, Anna Ostropolets, Rupa Makadia, et al.
American Journal of Epidemiology|August 31, 2000
Air quality and pediatric emergency room visits for asthma in Atlanta, Georgia, USAP E Tolbert, J A Mulholland, D L MacIntosh, et al.
Molecular Cell|August 18, 2022
Chromatin-bound RB targets promoters, enhancers, and CTCF-bound loci and is redistributed by cell-cycle progressionIoannis Sanidas, Hanjun Lee, Purva H Rumde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Combined clinical trial results of a HER2/neu (E75) vaccine for the prevention of recurrence in high-risk breast cancer patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02George E Peoples, Jarrod P Holmes, Matthew T Hueman, et al.
Oral Oncology|October 2, 2024
Loss of MACROD2 drives radioresistance but not cisplatin resistance in HPV-positive head and neck cancerAlice Dawson, Amir Hossein Karimi, Mushfiq H Shaikh, et al.
Cellular and Molecular Life Sciences : CMLS|October 22, 2011
Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applicationsPaul Galvin, Damien Thompson, Katie B Ryan, et al.
American Journal of Otolaryngology|November 13, 2020
Aerosol and droplet generation from mandible and midface fixation: Surgical risk in the pandemic eraMichael J Ye, Dhruv Sharma, Vincent J Campiti, et al.
Journal of the American Medical Informatics Association : JAMIA|December 1, 2020
Towards clinical data-driven eligibility criteria optimization for interventional COVID-19 clinical trialsJae Hyun Kim, Casey N Ta, Cong Liu, et al.
Pageof 65

Showing results (581-590 of 649) with videos related to

Sort By:
Pageof 65
Oral Oncology|October 1, 2023
Loss of LRP1B expression drives acquired chemo and radio-resistance in HPV-positive head and neck cancerMushfiq H Shaikh, Alice Dawson, Stephenie D Prokopec, et al.
BJS Open|May 8, 2021
Prediction of 90-day mortality after surgery for colorectal cancer using standardized nationwide quality-assurance dataR P Vogelsang, R D Bojesen, E R Hoelmich, et al.
BMJ (Clinical Research Ed.)|June 21, 2022
Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort studyXintong Li, Anna Ostropolets, Rupa Makadia, et al.
American Journal of Epidemiology|August 31, 2000
Air quality and pediatric emergency room visits for asthma in Atlanta, Georgia, USAP E Tolbert, J A Mulholland, D L MacIntosh, et al.
Molecular Cell|August 18, 2022
Chromatin-bound RB targets promoters, enhancers, and CTCF-bound loci and is redistributed by cell-cycle progressionIoannis Sanidas, Hanjun Lee, Purva H Rumde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Combined clinical trial results of a HER2/neu (E75) vaccine for the prevention of recurrence in high-risk breast cancer patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02George E Peoples, Jarrod P Holmes, Matthew T Hueman, et al.
Oral Oncology|October 2, 2024
Loss of MACROD2 drives radioresistance but not cisplatin resistance in HPV-positive head and neck cancerAlice Dawson, Amir Hossein Karimi, Mushfiq H Shaikh, et al.
Cellular and Molecular Life Sciences : CMLS|October 22, 2011
Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applicationsPaul Galvin, Damien Thompson, Katie B Ryan, et al.
American Journal of Otolaryngology|November 13, 2020
Aerosol and droplet generation from mandible and midface fixation: Surgical risk in the pandemic eraMichael J Ye, Dhruv Sharma, Vincent J Campiti, et al.
Journal of the American Medical Informatics Association : JAMIA|December 1, 2020
Towards clinical data-driven eligibility criteria optimization for interventional COVID-19 clinical trialsJae Hyun Kim, Casey N Ta, Cong Liu, et al.
Pageof 65